Jeffrey M Testani1,2, Jennifer S Hanberg2, Juan Pablo Arroyo2, Meredith A Brisco3, Jozine M Ter Maaten2,4, F Perry Wilson1,2, Lavanya Bellumkonda1, Daniel Jacoby1, W H Wilson Tang5, Chirag R Parikh1,2. 1. Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA. 2. Program of Applied Translational Research, Yale University School of Medicine, New Haven, CT, USA. 3. Department of Medicine, Cardiovascular Division, Medical University of South Carolina, Charleston, SC, USA. 4. Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands. 5. Section of Heart Failure and Cardiac Transplantation, Cleveland Clinic, Cleveland, OH, USA.
Abstract
AIMS: Hyponatraemia is strongly associated with adverse outcomes in heart failure. However, accumulating evidence suggests that chloride may play an important role in renal salt sensing and regulation of neurohormonal and sodium-conserving pathways. Our objective was to determine the prognostic importance of hypochloraemia in patients with heart failure. METHODS AND RESULTS: Patients in the BEST trial with baseline serum chloride values were evaluated (n = 2699). Hypochloraemia was defined as a serum chloride ≤96 mmol/L and hyponatraemia as serum sodium ≤135 mmol/L. Hypochloraemia was present in 13.0% and hyponatraemia in 13.7% of the population. Chloride and sodium were only modestly correlated (r = 0.53), resulting in only 48.7% of hypochloraemic patients having concurrent hyponatraemia. Both hyponatraemia and hypochloraemia identified a population with greater disease severity; however, renal function tended to be worse and loop diuretic doses higher with hypochloraemia. In univariate analysis, lower serum sodium or serum chloride as continuous parameters were each strongly associated with mortality (P < 0.001). However, when both parameters were included in the same model, serum chloride remained strongly associated with mortality [hazard ratio (HR) 1.3 per standard deviation decrease, 95% confidence interval (CI) 1.18-1.42, P < 0.001], whereas sodium was not (HR 0.97 per standard deviation decrease, 95% CI 0.89-1.06, P = 0.52). CONCLUSION: Serum chloride is strongly and independently associated with worsened survival in patients with chronic heart failure and accounted for the majority of the risk otherwise attributable to hyponatraemia. Given the critical role of chloride in a number of regulatory pathways central to heart failure pathophysiology, additional research is warranted in this area.
AIMS: Hyponatraemia is strongly associated with adverse outcomes in heart failure. However, accumulating evidence suggests that chloride may play an important role in renal salt sensing and regulation of neurohormonal and sodium-conserving pathways. Our objective was to determine the prognostic importance of hypochloraemia in patients with heart failure. METHODS AND RESULTS:Patients in the BEST trial with baseline serum chloride values were evaluated (n = 2699). Hypochloraemia was defined as a serum chloride ≤96 mmol/L and hyponatraemia as serum sodium ≤135 mmol/L. Hypochloraemia was present in 13.0% and hyponatraemia in 13.7% of the population. Chloride and sodium were only modestly correlated (r = 0.53), resulting in only 48.7% of hypochloraemic patients having concurrent hyponatraemia. Both hyponatraemia and hypochloraemia identified a population with greater disease severity; however, renal function tended to be worse and loop diuretic doses higher with hypochloraemia. In univariate analysis, lower serum sodium or serum chloride as continuous parameters were each strongly associated with mortality (P < 0.001). However, when both parameters were included in the same model, serum chloride remained strongly associated with mortality [hazard ratio (HR) 1.3 per standard deviation decrease, 95% confidence interval (CI) 1.18-1.42, P < 0.001], whereas sodium was not (HR 0.97 per standard deviation decrease, 95% CI 0.89-1.06, P = 0.52). CONCLUSION: Serum chloride is strongly and independently associated with worsened survival in patients with chronic heart failure and accounted for the majority of the risk otherwise attributable to hyponatraemia. Given the critical role of chloride in a number of regulatory pathways central to heart failure pathophysiology, additional research is warranted in this area.
Authors: Eric J Eichhorn; Michael J Domanski; Heidi Krause-Steinrauf; Michael R Bristow; Philip W Lavori Journal: N Engl J Med Date: 2001-05-31 Impact factor: 91.245
Authors: Alexander T Piala; Thomas M Moon; Radha Akella; Haixia He; Melanie H Cobb; Elizabeth J Goldsmith Journal: Sci Signal Date: 2014-05-06 Impact factor: 8.192
Authors: Frederick H Wilson; Kristopher T Kahle; Ernesto Sabath; Maria D Lalioti; Alicia K Rapson; Robert S Hoover; Steven C Hebert; Gerardo Gamba; Richard P Lifton Journal: Proc Natl Acad Sci U S A Date: 2003-01-06 Impact factor: 11.205
Authors: Jennifer S Hanberg; Veena Rao; Jozine M Ter Maaten; Olga Laur; Meredith A Brisco; F Perry Wilson; Justin L Grodin; Mahlet Assefa; J Samuel Broughton; Noah J Planavsky; Tariq Ahmad; Lavanya Bellumkonda; W H Wilson Tang; Chirag R Parikh; Jeffrey M Testani Journal: Circ Heart Fail Date: 2016-08 Impact factor: 8.790
Authors: Tawfeq Naal; Batool Abuhalimeh; Ghaleb Khirfan; Raed A Dweik; W H Wilson Tang; Adriano R Tonelli Journal: Chest Date: 2018-04-24 Impact factor: 9.410